Chronic Lymphocytic Leukemia

<p>Written by authors from the world’s most prominent cancer centers <strong><em>Chronic Lymphocytic Leukemia</em></strong> supplies a comprehensive up-to-date picture of CLL and how to better treat patients inflicted with the disease.</p><p>New information on developments in the molecular pathogenesis of this disease impacts how physicians approach and treat patients with CLL. The various predisposing factors for the disease are addressed along with current and future treatment modalities and recommended standards of care.</p><p>Key features include:</p><ul> <ul> </ul> <li>introduction by Kanti Rai MD who developed the Rai Classification and Staging system used in CLL diagnosis</li> <li>CLL in relationship to gene expression profiling and molecular abnormalities</li> <li>familial clustering and gene predisposition</li> <li>targeted therapy trials</li> <li>clinical patient management based upon stage and progression of disease</li> </ul>